Shanghai Taichu Biotechnology
Latest round
- Series A
Last raised
- May 2023
Total raised
- $102M
Investors
- 13
About Shanghai Taichu Biotechnology
Established in 2020 and based in Shanghai, China, Skynor Medical operates as a CRO and CDMO customized services provider that provides CRO and CDMO technical services. Taijin Biology, Taili Biology, Taizhen Biology, and Taiji Biology are the subsidiaries of the company. The company provides CRO and CDMO technical services. CRO services include evaluation of non clinical drug efficacy in biopharmaceuticals and discovery of antibody drugs. CDMO services include R&D and production of antibody drug processes, high-end formulation delivery systems, and small nucleic acid processes.
Who invested in Shanghai Taichu Biotechnology
13 investors across 2 rounds
See all investors in Shanghai Taichu Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Shanghai Taichu Biotechnology
Who invested in Shanghai Taichu Biotechnology?
Shanghai Taichu Biotechnology has 13 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shanghai Taichu Biotechnology raised?
Shanghai Taichu Biotechnology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Shanghai Taichu Biotechnology last raise money?
Shanghai Taichu Biotechnology's most recent round on record is a Series A, in May 2023.
What does Shanghai Taichu Biotechnology do?
Established in 2020 and based in Shanghai, China, Skynor Medical operates as a CRO and CDMO customized services provider that provides CRO and CDMO technical services.
Where is Shanghai Taichu Biotechnology headquartered?
Shanghai Taichu Biotechnology is headquartered in Shanghai, China.
Which VCs invest in companies like Shanghai Taichu Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back outsourcing companies at Shanghai Taichu Biotechnology's stage. Their profiles are linked below.
VCs backing outsourcing startups at Series A
Raising like Shanghai Taichu Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.